KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite

scientific article published on 9 February 2018

KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0192659
P932PMC publication ID5806893
P698PubMed publication ID29425228

P50authorSerge BarcyQ95993335
Soren GanttQ42647995
P2093author name stringTimothy M Rose
Qing Zhang
Ryan Basom
Yuko Ogata
Corey Casper
Michael R Dyen
Minako Ikoma
P2860cites workKaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cellsQ24555724
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell linesQ24594085
The microRNA RegistryQ24600787
Secretory mechanisms and intercellular transfer of microRNAs in living cellsQ24603413
Upregulated miR-106a plays an oncogenic role in pancreatic cancerQ53071807
MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.Q53280332
Kaposi's SarcomaQ54197804
Heterogeneity of the Ro/SSA antigen and autoanti-Ro/SSA response: evidence of the four antigenically distinct formsQ68872895
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcomaQ72633360
Association of a pool of HIV-1 with erythrocytes in vivo: a cohort studyQ74424811
EBV-encoded miRNAsQ84271499
The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response elementQ40758382
HIV and complement: role of the complement system in HIV infection.Q40807008
MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathyQ40848218
An information-intensive approach to the molecular pharmacology of cancer.Q41134023
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.Q41839438
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.Q42365746
Circulating red cell-derived microparticles in human malariaQ42712727
5'-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasmaQ43789607
Complement changes in falciparum malaria infectionQ44226083
Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlatesQ45117910
Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stageQ45739908
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathwayQ46255425
Tumor-derived exosomes modulate PD-L1 expression in monocytes.Q46329110
Cancer in Africa: epidemiology and preventionQ46412074
The distinct proteome of placental malaria parasitesQ47837556
von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activationQ48028775
Complement Activation in Severe Plasmodium falciparum MalariaQ48037526
Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis.Q36712914
MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1.Q36870550
OncomiRs: the discovery and progress of microRNAs in cancersQ36951319
Role of transforming growth factor-beta superfamily signaling pathways in human diseaseQ37099520
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcomaQ37237479
Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23Q37252707
MicroRNA function in cancer: oncogene or a tumor suppressor?Q37655612
BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinomaQ37659154
Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood.Q37669854
Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial CellsQ37727998
Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.Q37888397
MicroRNAs as mediators of viral evasion of the immune systemQ38082296
The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding proteinQ38335734
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage studyQ38399107
Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAsQ38610039
MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinomaQ38739661
RNY (YRNA)-derived small RNAs regulate cell death and inflammation in monocytes/macrophagesQ39038743
An update: Epstein-Barr virus and immune evasion via microRNA regulation.Q39409293
Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosisQ39454179
Complement mediates the binding of HIV to erythrocytesQ40517628
Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assayQ40559469
Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression.Q40635375
Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malariaQ40666888
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expressionQ40686716
miR-221 Is Required for Endothelial Tip Cell Behaviors during Vascular DevelopmentQ24630712
Circulating microRNAs as stable blood-based markers for cancer detectionQ24652098
A viral microRNA functions as an orthologue of cellular miR-155Q24652947
Functional requirement of noncoding Y RNAs for human chromosomal DNA replicationQ24670318
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155Q24681400
KSHV-Mediated Angiogenesis in Tumor ProgressionQ26742030
"Asymptomatic" Malaria: A Chronic and Debilitating Infection That Should Be TreatedQ26771205
Measurement of protein using bicinchoninic acidQ26778491
Functional roles of non-coding Y RNAsQ26866273
Cell-cell communication between malaria-infected red blood cells via exosome-like vesiclesQ27973498
Exosomes as miRNA Carriers: Formation-Function-FutureQ28075728
Identification of virus-encoded microRNAsQ28259309
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID miceQ28262487
RNAi, microRNAs, and human diseaseQ28273238
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Q29547403
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsQ29615034
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancerQ29616316
Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0.Q31125225
A subset of hY RNAs is associated with erythrocyte Ro ribonucleoproteinsQ33258130
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in UgandaQ33401242
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Q33432690
Targeting the transforming growth factor-beta signaling pathway in human cancerQ33517772
Plasma levels of apolipoprotein A1 in malaria-exposed primigravidae are associated with severe anemiaQ33526296
Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapyQ33610926
KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicineQ33761091
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral InfectionsQ33817618
Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirusQ33883910
Mucosal shedding of human herpesvirus 8 in men.Q33924644
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcomaQ33974199
New inflammation-related biomarkers during malaria infectionQ34058614
Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosisQ34102689
Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infectionQ34257818
Kaposi's Sarcoma-Associated Herpesvirus microRNAsQ34273195
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cellsQ34307544
Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.Q34347568
Augmented plasma microparticles during acute Plasmodium vivax infectionQ34388168
Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomasQ34395302
Regulation of herpesvirus lifecycle by viral microRNAsQ34412460
MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locusQ34453771
HIV infection and human herpesvirus-8 oral shedding among men who have sex with men.Q34547024
A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesvirusesQ34547697
miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-MybQ34571580
Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesisQ34580878
Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formationQ34594849
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigenQ34735858
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaQ34784133
Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.Q34845533
The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivoQ34973323
Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturationQ35077455
Identification of circulating biomarkers in sera of Plasmodium knowlesi-infected malaria patients--comparison against Plasmodium vivax infectionQ35108515
EVpedia: a community web portal for extracellular vesicles researchQ35221358
Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in UgandaQ35328464
A brief review on biomarkers and proteomic approach for malaria researchQ35632089
Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosisQ35670992
Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.Q35689725
Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.Q35784707
Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.Q35834474
A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathwayQ35983671
Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell LinesQ36128494
RNY-derived small RNAs as a signature of coronary artery diseaseQ36142332
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settingsQ36162341
Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men.Q36247828
MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virionsQ36397498
Kaposi's sarcoma and its associated herpesvirusQ36487309
Factors determining the occurrence of submicroscopic malaria infections and their relevance for controlQ36503207
Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive personsQ36565716
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptorQ36591375
Principles and effects of microRNA-mediated post-transcriptional gene regulation.Q36617803
Cells release subpopulations of exosomes with distinct molecular and biological propertiesQ36638253
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesDESeq2Q113018293
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmalariaQ12156
microRNA expressionQ60681249
P304page(s)e0192659
P577publication date2018-02-09
P1433published inPLOS OneQ564954
P1476titleKSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite
P478volume13

Search more.